Researchers call for transparent ethic committees

September 29, 2016 by Dominic Younger, University of Dundee
Researchers call for transparent ethic committees
Credit: University of Dundee

Poor regulation of research can cause direct harm to patients, suggests a new research study led by the University of Dundee.

The international study led by Dr Jonathan Mendel from the University has called for greater transparency in ethics committee processes.

The report, which saw input from researchers across the UK and Australia, has been published in the British Medical Journal (BMJ).

Investigating the process of ethical approval and the information given to patients with rheumatoid arthritis in , the study suggests that by making documentation freely available, it will allow ethical decisions to be independently reviewed, publicly discussed, and learnt from.

It further suggests that systematic review of evidence could allow for more effective scrutiny by Research Ethics Committees prior to publication.

Dr Mendel, a Lecturer in Human Geography whose research covers social aspects of trials amongst other areas, said, "We have shown that ethics processes around trials can lead to problematic decisions, which risk having significant impact on trial participants.

"Ethics processes are important to society, and should be open to public scrutiny. This is vital, both to minimise avoidable participant harms and to maintain public trust."

Dr Ben Goldacre from the University of Oxford, said, "Transparency for clinical trials is now firmly on the agenda with campaigns such as AllTrials. But transparency requires more than trial results. We can only be confident that patients' interests are being protected if all consent forms and ethics deliberations are publicly available."

Explore further: Big pharma inconsistent with disclosure of information on clinical trials, new study finds

More information: Jonathan Mendel et al. Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis, BMJ (2016). DOI: 10.1136/bmj.i4626

Related Stories

Big pharma inconsistent with disclosure of information on clinical trials, new study finds

November 12, 2015
Despite legal and ethical requirements, information on clinical trials for drugs approved by the U.S. Food and Drug Administration (FDA) varied widely among some of the world's largest drug companies, according to a new study ...

Discontinuation of randomized clinical trials common

March 11, 2014
Approximately 25 percent of about 1,000 randomized clinical trials initiated between 2000 and 2003 were discontinued, with the most common reason cited being poor recruitment of volunteers; and less than half of these trials ...

New WHO statement on public reporting of clinical trial results announced

April 14, 2015
The World Health Organization (WHO) have announced a new statement on the public disclosure of clinical trial results which updates and expands a previous statement that noted the "the registration of all interventional trials ...

Calls for greater transparency in the release of clinical trial data

September 20, 2016
Researchers have called for greater transparency in the public release of clinical trial data after a study revealed significant under-reporting of side effects in medical treatments.

Industry-academia publication agreements include limits on publication of trial results

June 28, 2016
Publication agreements constraining academic investigators' independence are common, and incompletely reported in publications, according to a study published in this week's PLOS Medicine. The study, conducted by Matthias ...

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.